Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904453882> ?p ?o ?g. }
- W2904453882 endingPage "3069" @default.
- W2904453882 startingPage "3056" @default.
- W2904453882 abstract "Toll-like receptors (TLRs) play critical roles in host defense after recognition of conserved microbial- and host-derived components, and their dysregulation is a common feature of various inflammation-associated cancers, including gastric cancer (GC). Despite the recent recognition that metabolic reprogramming is a hallmark of cancer, the molecular effectors of altered metabolism during tumorigenesis remain unclear. Here, using bioenergetics function assays on human GC cells, we reveal that ligand-induced activation of TLR2, predominantly through TLR1/2 heterodimer, augments both oxidative phosphorylation (OXPHOS) and glycolysis, with a bias toward glycolytic activity. Notably, DNA microarray-based expression profiling of human cancer cells stimulated with TLR2 ligands demonstrated significant enrichment of gene-sets for oncogenic pathways previously implicated in metabolic regulation, including reactive oxygen species (ROS), p53 and Myc. Moreover, the redox gene encoding the manganese-dependent mitochondrial enzyme, superoxide dismutase (SOD)2, was strongly induced at the mRNA and protein levels by multiple signaling pathways downstream of TLR2, namely JAK-STAT3, JNK MAPK and NF-κB. Furthermore, siRNA-mediated suppression of SOD2 ameliorated the TLR2-induced metabolic shift in human GC cancer cells. Importantly, patient-derived tissue microarrays and bioinformatics interrogation of clinical datasets indicated that upregulated expression of TLR2 and SOD2 were significantly correlated in human GC, and the TLR2-SOD2 axis was associated with multiple clinical parameters of advanced stage disease, including distant metastasis, microvascular invasion and stage, as well as poor survival. Collectively, our findings reveal a novel TLR2-SOD2 axis as a potential biomarker for therapy and prognosis in cancer." @default.
- W2904453882 created "2018-12-22" @default.
- W2904453882 creator A5008563217 @default.
- W2904453882 creator A5017331738 @default.
- W2904453882 creator A5018056806 @default.
- W2904453882 creator A5035819588 @default.
- W2904453882 creator A5038763827 @default.
- W2904453882 creator A5045740459 @default.
- W2904453882 creator A5046658506 @default.
- W2904453882 creator A5055490340 @default.
- W2904453882 creator A5055754182 @default.
- W2904453882 creator A5061399482 @default.
- W2904453882 creator A5077496329 @default.
- W2904453882 creator A5079399767 @default.
- W2904453882 creator A5083389160 @default.
- W2904453882 date "2019-01-07" @default.
- W2904453882 modified "2023-10-17" @default.
- W2904453882 title "Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer <i>via</i> superoxide dismutase 2" @default.
- W2904453882 cites W1529706570 @default.
- W2904453882 cites W1571252195 @default.
- W2904453882 cites W1965009601 @default.
- W2904453882 cites W1977039417 @default.
- W2904453882 cites W1984543978 @default.
- W2904453882 cites W1989357594 @default.
- W2904453882 cites W2000323986 @default.
- W2904453882 cites W2000326742 @default.
- W2904453882 cites W2004601117 @default.
- W2904453882 cites W2015732113 @default.
- W2904453882 cites W2018711046 @default.
- W2904453882 cites W2019357766 @default.
- W2904453882 cites W2027253055 @default.
- W2904453882 cites W2029436635 @default.
- W2904453882 cites W2036159933 @default.
- W2904453882 cites W2037434205 @default.
- W2904453882 cites W2055408625 @default.
- W2904453882 cites W2057075868 @default.
- W2904453882 cites W2061070237 @default.
- W2904453882 cites W2078344366 @default.
- W2904453882 cites W2088095644 @default.
- W2904453882 cites W2092078309 @default.
- W2904453882 cites W2101416237 @default.
- W2904453882 cites W2109491705 @default.
- W2904453882 cites W2120027682 @default.
- W2904453882 cites W2122378278 @default.
- W2904453882 cites W2154745279 @default.
- W2904453882 cites W2160376442 @default.
- W2904453882 cites W2161162542 @default.
- W2904453882 cites W2170661703 @default.
- W2904453882 cites W2197588452 @default.
- W2904453882 cites W2223535266 @default.
- W2904453882 cites W2256675122 @default.
- W2904453882 cites W2292613448 @default.
- W2904453882 cites W2346299902 @default.
- W2904453882 cites W2406801487 @default.
- W2904453882 cites W2409563214 @default.
- W2904453882 cites W2503851771 @default.
- W2904453882 cites W2522038806 @default.
- W2904453882 cites W2562449006 @default.
- W2904453882 cites W2586265133 @default.
- W2904453882 cites W2605743056 @default.
- W2904453882 cites W2612260650 @default.
- W2904453882 cites W2756048879 @default.
- W2904453882 cites W2757522502 @default.
- W2904453882 cites W2765794440 @default.
- W2904453882 cites W2782670265 @default.
- W2904453882 cites W2788659688 @default.
- W2904453882 cites W4231565327 @default.
- W2904453882 cites W436409139 @default.
- W2904453882 doi "https://doi.org/10.1002/ijc.32060" @default.
- W2904453882 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6590666" @default.
- W2904453882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30536754" @default.
- W2904453882 hasPublicationYear "2019" @default.
- W2904453882 type Work @default.
- W2904453882 sameAs 2904453882 @default.
- W2904453882 citedByCount "35" @default.
- W2904453882 countsByYear W29044538822019 @default.
- W2904453882 countsByYear W29044538822020 @default.
- W2904453882 countsByYear W29044538822021 @default.
- W2904453882 countsByYear W29044538822022 @default.
- W2904453882 countsByYear W29044538822023 @default.
- W2904453882 crossrefType "journal-article" @default.
- W2904453882 hasAuthorship W2904453882A5008563217 @default.
- W2904453882 hasAuthorship W2904453882A5017331738 @default.
- W2904453882 hasAuthorship W2904453882A5018056806 @default.
- W2904453882 hasAuthorship W2904453882A5035819588 @default.
- W2904453882 hasAuthorship W2904453882A5038763827 @default.
- W2904453882 hasAuthorship W2904453882A5045740459 @default.
- W2904453882 hasAuthorship W2904453882A5046658506 @default.
- W2904453882 hasAuthorship W2904453882A5055490340 @default.
- W2904453882 hasAuthorship W2904453882A5055754182 @default.
- W2904453882 hasAuthorship W2904453882A5061399482 @default.
- W2904453882 hasAuthorship W2904453882A5077496329 @default.
- W2904453882 hasAuthorship W2904453882A5079399767 @default.
- W2904453882 hasAuthorship W2904453882A5083389160 @default.
- W2904453882 hasBestOaLocation W29044538821 @default.
- W2904453882 hasConcept C121608353 @default.
- W2904453882 hasConcept C2775838275 @default.
- W2904453882 hasConcept C2776070231 @default.